Human antibody-Fc receptor interactions illuminated by crystal structures

Nature Reviews Immunology

Volumn 4, Issue 2, 2004, Pages 89-99

  Woof, Jenny M ^a   Burton, Dennis R ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FC ALPHA RECEPTOR I; FC EPSILON RECEPTOR I; FC EPSILON RECEPTOR II; FC EPSILON RECEPTOR IIA; FC EPSILON RECEPTOR IIB; FC RECEPTOR; FC RECEPTOR I; FC RECEPTOR IA; FC RECEPTOR II; FC RECEPTOR IIA; FC RECEPTOR IIB; FC RECEPTOR IIC; FC RECEPTOR III; FC RECEPTOR IIIA; FC RECEPTOR IIIB; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; CRYSTAL STRUCTURE; EFFECTOR CELL; HUMAN; IMMUNOGLOBULIN STRUCTURE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TARGET CELL;

EID: 1142298744     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1266     Document Type: Review

References (97)

1. Huber, R., Deisenhofer, J., Colman, P. M., Matsushima, M. & Palm, W. Crystallographic structure studies of an IgG molecule and an Fc fragment. Nature 264, 415-420 (1976).
2. Deisenhofer, J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 and 2.8 Å resolution. Biochemistry 20, 2361-2370 (1981).
3. 2 and its receptor FcεRI.
4. Wurzburg, B. A., Garman, S. C. & Jardetzky, T. S. Structure of the human IgE-Fc Cε3-Cε4 reveals conformational flexibility in the antibody effector domains. Immunity 13, 375-385 (2000).
5. 2 was determined and compared with that of the Fc region lacking the Cε2 domains, both uncomplexed and complexed to FcεRI.
6. Herr, A. B., Ballister, E. R. & Bjorkman, P. J. Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc. Nature 423, 614-620 (2003). This paper reported the X-ray crystal structure of IgA complexed with FcαRI.
7. Davis, K. G., Glennie, M. J., Harding, S. E. & Burton, D. R. A model for the solution conformation of rat IgE. Biochem. Soc. Trans. 18, 935-936 (1990).
8. Zheng, Y., Shopes, B., Holowka, D. & Baird, B. Conformations of IgE bound to its receptor FcεRI and in solution. Biochemistry 30, 9125-9132 (1991).
9. Harris, L. J. et al. The three-dimensional structure of an intact monoclonal antibody for canine lymphoma. Nature 360, 369-372 (1992).
10. Harris, L. J., Skaletsky, E. & McPherson, A. Crystallographic structure of an intact IgG1 monoclonal antibody. J. Mol. Biol. 275, 861-872 (1998).
11. Saphire, E. O. et al. Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design. Science 293, 1155-1159 (2001).
12. Saphire, E. O. et al. Contrasting IgG structures reveal extreme asymmetry and flexibility. J. Mol. Biol. 319, 9-18 (2002). This paper provides insights into the structure and flexibility of IgG through comparison of the X-ray crystal structures of intact IgG molecules.
13. Bloth, B. & Svehag, S. E. Further studies on the ultrastructure of dimeric IgA of human origin. J. Exp. Med. 133, 1035-1042 (1971).
14. Munn, E. A., Feinstein A. & Munro A. J. Electron microscope examination of free molecules and of their complexes with antigen. Nature 231, 527-529 (1971).
15. Dourmashkin, R. R., Virella, G. & Parkhouse, R. M. Electron microscopy of human and mouse myeloma serum IgA. J. Mol. Biol. 56, 207-208 (1971).
16. Roux, K. H., Strelets, L., Brekke, O. H., Sandlie, I. & Michaelsen, T. E. Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE, and IgA2, to form small immune complexes: a role for flexibility and geometry. J. Immunol. 181, 4083-4090 (1998).
17. Boehm, M. K., Woof, J. M., Kerr, M. A. & Perkins, S. J. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling. J. Mol. Biol. 286, 1421-1447 (1999).
18. Zheng, Y., Shopes, B., Holowka, D. & Baird, B. Dynamic conformations compared for IgE and IgG1 in solution and bound to receptors. Biochemistry 31, 7446-7456 (1992).
19. Burton, D. R. & Woof, J. M. Human antibody effector function. Adv. Immunol. 51, 1-84 (1992).
20. van de Winkel, J. G. J. & Hogarth, P. M. The Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity. (Kluwer Academic Publishers, Dordrecht, 1998).
21. Salmon, J. E. & Pricop, L. Human receptors for immunoglobulin G. Arthritis Rheum. 44, 739-750 (2001).
22. Monteiro, R. C. & van de Winkel, J. G. J. IgA Fc receptors. Annu. Rev. Immunol. 21, 177-204 (2003).
23. Reth, M. Antigen receptor tail clue. Nature 338, 383-384 (1989).
24. Ravetch, J. V. Fc receptors. Curr. Opin. Immunol. 9, 121-125 (1997).
25. Kremer, E. J. et al. The gene for the human IgA Fc receptor maps to 19q13. 4. Hum. Genet. 89, 107-108 (1992).
26. Wende, H., Colonna, M., Ziegler, A. & Volz, A. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13. 4. Mamm. Genome 10, 154-160 (1999).
27. Metzger, H. Molecular versatility of antibodies. Immunol. Rev. 185, 186-205 (2002).
28. Segal, D. M., Taurog, J. D. & Metzger, H. Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. Proc. Natl Acad Sci. USA 74, 2993-2997 (1977).
29. Rivera, J. Molecular adapters in FcεRI signaling and the allergic response. Curr. Opin. Immunol. 14, 688-693 (2002).
30. Eiseman, E. & Bolen, J. B. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 355, 78-80 (1992).
31. Guile, H., Samstag, A., Eibl, M. M. & Wolf, H. M. Physical and functional association of FcαR with protein tyrosine kinase Lyn. Blood 91, 383-391 (1998).
32. Petty, H. R., Worth, R. G. & Todd, R. F. Interactions of integrins with their partner proteins in leukocyte membranes. Immunol. Res. 25, 75-95 (2002).
33. van Egmond, M. et al. Human immunoglobulin A receptor (FcαRI, CD89) function in transgenic mice requires both FcR γ chain and CR3 (CD11b/CD18). Blood 93, 4387-4394 (1999).
34. van Spriel, A. B., Leusen, J. H., Vile, H. & van de Winkel, J. G. J. Mac-1 (CD11b/CD18) as accessory molecule for FcαR (CD89) binding of IgA. J. Immunol. 189, 3831-3836 (2002).
35. Maxwell, K. F. et al. Crystal structure of the human leukocyte Fc receptor, FcγRIIa. Nature Struct. Biol. 6, 437-442 (1999).
36. Sondermann, P., Kaiser, J. & Jacob, U. Molecular basis for immune complex recognition: a comparison of Fc-receptor structures. J. Mol. Biol. 309, 737-749 (2001).
37. Sondermann, P., Huber, R. & Jacob, U. Crystal structure of the soluble form of the human Fcγ-receptor IIb: a new member of the immunoglobulin superfamily at 1.7 Å resolution. EMBO J. 18, 1095-1103 (1999).
38. Sondermann, P., Huber, R., Oosthuizen, V. & Jacob, U. The 3. 2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature 406, 267-273 (2000). This paper and reference 40 describe the X-ray crystal structure of the complex between IgG1 and FCγRIII.
39. Zheng, Y. et al. Crystal structure of the extracellular domain of a human FcγRIII. Immunity 13, 387-395 (2000).
40. Radaev S., Motyka S., Fridman W.-H., Sautes-Fridman C. & Sun P. D. The structure of a human type III Fcγ receptor in complex with Fc. J. Biol. Chem. 276, 16469-16477 (2001).
41. Garman, S. C., Kinet, J.-P. & Jardetzky, T. S. Crystal structure of the human high-affinity IgE receptor. Cell 95, 951-961 (1998).
42. Garman, S. C., Sechi, S., Kinet, J. P. & Jardetzky, T. S. The analysis of the human high affinity IgE receptor FcεRIα from multiple crystal forms. J. Mol. Biol. 311, 1049-1062 (2001).
43. Ding, Y. et al. Crystal structure of the ectodomain of human FcαRI. J. Biol. Chem. 278, 27966-27970 (2003).
44. Fan, Q. R. et al. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature 389, 96-100 (1997).
45. Chapman, T. L., Heikema, A. P., West, A. P. & Bjorkman, P. J. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 13, 727-736 (2000).
46. Hulett, M. D. & Hogarth, P. M. The second and third extracellular domains of FcγRI (CD64) confer the unique high affinity binding of IgG2a. Mol. Immunol. 35, 989-996 (1998).
47. Hulett, M. D., Witort, E., Brinkworth, R. I., McKenzie, I. F. & Hogarth, P. M. Identification of the IgG binding site of the human low affinity receptor for IgG FcγRII. Enhancement and ablation of binding by site-directed mutagenesis. J. Biol. Chem. 269, 15287-15293 (1994).
48. Hulett, M. D., Witort, E., Brinkworth, R. I., McKenzie, I. F. & Hogarth, P. M. Multiple regions of human FcγRII (CD32) contribute to the binding of IgG. J. Biol. Chem. 270, 21188-21194 (1995).
49. Tamm, A., Kister, A., Nolte, K. U., Gessner, J. E. & Schmidt, R. E. The IgG binding site of human FcγRII receptor involves CC' and FG loops of the membrane-proximal domain. J. Biol. Chem. 271, 3659-3666 (1996).
50. Woof, J. M., Partridge, L. J., Jefferis R. & Burton, D. R. Localisation of the monocyte-binding region on human immunoglobulin G. Mol. Immunol. 23, 319-330 (1986).
51. Duncan, A. R., Woof, J. M., Partridge, L. J., Burton, D. R. & Winter, G. Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature 332, 563-564 (1988).
52. Lund, J. et al. Human FcγRI and FcγRII interact with distinct but overlapping sites on human IgG. J. Immunol. 147, 2657-2662 (1991).
53. Chappel, M. S. et al. Identification of the Fcγ-receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. Proc. Natl Acad. Sci. USA 88, 9036-9040 (1991).
54. Canfield, S. M. & Morrison, S. L. The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region. J. Exp. Med. 173, 1483-1491 (1991).
55. Hulett, M. D., Brinkworth, R. I., McKenzie, I. F. & Hogarth, P. M. Fine structure analysis of interaction of FcεRI with IgE. J. Biol. Chem. 274, 13345-13352 (1999).
56. Henry, A. J. et al. Participation of the N-terminal region of Cε3 in the binding of human IgE to its high-affinity receptor FcεeRI, Biochemistry 38, 15568-15578 (1997).
57. Sayers I. & Helm, B. A. The structural basis of human IgE-Fc receptor interactions. Clin. Exp. Allergy 29, 585-594 (1999).
58. McDonnell, J. M. et al. The structure of the IgE Cε2 domain and its role in stabilizing the complex with its high-affinity receptor FcεRIα. Nature Struct. Biol. 8, 437-441 (2001).
59. Sechi, S., Roller, P. P., Willett-Brown, J. & Kinet, J.-P. A conformational rearrangement upon binding of IgE to its high affinity receptor. J. Biol. Chem. 32, 19256-19263 (1996).
60. Nechansky, A. et al. Interaction of human IgE with FcεRIa exposes hidden epitopes on IgE. Int. Arch. Allergy Immunol. 120, 295-302 (1999).
61. Carayannopoulos, L., Hexham, J. M. & Capra, J. D. Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Cα2 and Cα3 in human IgA1. J. Exp. Med. 183, 1579-1586 (1996).
62. Pleass, R. J., Dunlop, J. I., Anderson, C. M. & Woof, J. M. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human Fcα receptor (FcαR) CD89. J. Biol. Chem. 274, 23508-23514 (1999).
63. Wines, B. D. et al. Identification of residues in the first domain of human Fcα receptor essential for interaction with IgA. J. Immunol. 162, 2146-2153 (1999).
64. Morton, H. C. et al. Immunoglobulin-binding sites of human FcαRI (CD89) and bovine Fcγ2R are located in their membrane-distal extracellular domains. J. Exp. Med. 189, 1715-1722 (1999).
65. Wines, B. D., Sardjono, C. T., Trist, H. M., Lay, C.-S. & Hogarth, P. M. The interaction of FcαRI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. J. Immunol. 166, 1781-1789 (2001).
66. Herr, A. B., White, C. L., Milbum, C., Wu, C. & Bjorkman, P. J. Bivalent binding of IgA1 to FcαRI suggests a mechanism for cytokine activation of IgA phagocytosis. J. Mol. Biol. 327, 645-657 (2003). Using analytical ultracentrifugation and equilibrium gel-filtration experiments, this study indicated that, in solution, two molecules of IgA1 can bind to one molecule of FcαRI.
67. Pleass, R. J., Dehal, P. K., Lewis, M. J. & Woof, J. M. Limited role of charge matching in the interaction of human immunoglobulin A (IgA) with the IgA Fc receptor (FcαRI) CD89. Immunology 109, 331-335 (2003).
68. Mattu, T. S. et al. The glycosylation and structure of human serum IgA1, Fab and Fc regions and the role of N-glycosylation on FcαR interactions. J. Biol. Chem. 273, 2260-2272 (1998).
69. van Egmond, M. et al. FcαRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nature Med. 8, 680-685 (2000).
70. Stewart, W. W. & Kerr, M. A. The specificity of the human neutrophil IgA receptor (FcαR) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2. Immunology 71, 328-334 (1990).
71. Sauer-Eriksson, A. E., Kleywegt, G. J., Uhlen, M. & Jones, T. A. Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG. Structure 3, 265-278 (1995).
72. Martin, W. L., West, A. P. Jr, Gen, L. & Bjorkman, P. J. Crystal structure at 2.8 Å of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. Mol. Cell 7, 867-877 (2001).
73. Corper, A. L. et al. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nature Struct. Biol. 4, 374-381 (1997).
74. Pleass, R. J., Areschoug, T., Lindahl, G. & Woof, J. M. Streptococcal IgA-binding proteins bind in the Cα2-Cα3 interdomain region and inhibit binding of IgA to human CD89. J. Biol. Chem. 276, 8197-8204 (2001).
75. Burton, D. R. Immunoglobulin G: functional sites. Mol. Immunol. 22, 161-206 (1985).
76. DeLano, W. L., Ultsch, M. H., de Vos, A. M. & Wells, J. A. Convergent solutions to binding at a protein-protein interface. Science 287, 1279-1283 (2000).
77. Radaev, S. & Sun, P. Recognition of immunoglobulins by Fcγ receptors. Mol. Immunol. 38, 1073-1083 (2001).
78. Shields, R. L. et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity. J. Biol. Chem. 277, 26733-26740 (2002).
79. Shinkawa, T. et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 278, 3466-3473 (2003).
80. Krapp, S., Mimura, Y., Jefferis, R., Huber, R. & Sondermann, P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J. Mol. Biol. 325, 979-989 (2003).
81. Walker, M. R., Woof, J. M., Bruggemann, M., Jefferis, R. & Burton D. R. Interaction of human IgG chimeric antibodies with the human FcRI and FcRII receptors: recruitements for antibody-mediated host cell-target cell interaction. Mol. Immunol. 26, 403-411 (1989).
82. Burton, D. R. Antibody: the flexible adaptor molecule. Trends Biol. Sci. 15, 64-69 (1990).
83. Burton, D. R. Is IgM-like dislocation a common feature of antibody function? Immunol. Today 7, 165-167 (1986).
84. Field, K. A. Holowka D. & Baird B. Compartmentalized activation of the high affinity IgE receptor within membrane domains. J. Biol. Chem. 272, 4276-4280 (1997).
85. Lang, M. L., Shen, L. & Wade, W. F. γ-chain dependent recruitment of tyrosine kinases to membrane rafts by the human IgA receptor FcαR. J. Immunol. 163, 5391-5398 (1999).
86. Holowka, D. & Baird, B. FcεRI as a paradigm for a lipid raft-dependent receptor in hematopoietic cells. Semin. Immunol. 13, 99-105 (2001).
87. Kwiatkowska, K. & Sobota, A. The clustered Fcγ receptor II is recruited to Lyn-containing membrane domains and undergoes phosphorylation in a cholesterol-dependent manner. Eur. J. Immunol. 31, 989-998 (2001).
88. Katsumata, O. et al. Association of FcγRII with low-density detergent-resistant membranes is important for crosslinking-dependent initiation of the tyrosine phosphorylation pathway and superoxide generation. J. Immunol. 167, 5814-5823 (2001).
89. Lang, M. L. et al. IgA Fc receptor (FcαR) crosslinking recruits tyrosine kinases, phosphoinositide kinases and serine/threonine kinases to glycolipid rafts. Biochem. J. 364, 517-525 (2002).
90. van Dijk, M. A. & van de Winkel, J. G. Human antibodies as next generation therapeutics. Curr. Opin. Chem. Biol. 5, 368-374 (2001).
91. Reichert, J. M. Therapeutic monoclonal antibodies: trends in development and approval in the US. Curr. Opin. Mol. Ther. 4, 110-118 (2002).
92. Brekke, O. H. & Sandlie, I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nature Rev. Drug Discov. 2, 52-62 (2003).
93. Waldmann, T. A. Immunotherapy: past, present and future. Nature Med. 9, 269-277 (2003).
94. Presta, L. G. Engineering antibodies for therapy. Curr. Pharmaceut. Biotechnol. 3, 237-256 (2002).
95. Corthésy, B. Recombinant immunoglobulin A: powerful tools for fundamental and applied research. Trends Biotechnol. 20, 65-71 (2002).
96. Silverton, E. W., Navia, M. A. & Davies, D. R. Three-dimensional structure of an intact human immunoglobulin. Proc. Natl Acad. Sci. USA 74, 5140-5144 (1977).
97. Guddat, L. W., Herron J. N. & Edmundson, A. B. Three-dimensional structure of a human immunoglobulin with a hinge deletion. Proc. Natl Acad. Sci. USA 90, 4271-4275 (1993).